Allergic Rhinitis
📧 Sign up to get email alerts when something new happens for Allergic Rhinitis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2009-03-30FDA Approved: CETRIZINE HYDROCHLORIDE — Original Application (APOZEAL PHARMACEUTICALS INC)
FDA approved cetirizine hydrochloride from APOZEAL Pharmaceuticals Inc as an original application; a generic antihistamine indicated for all…
-
FDA approval · 2009-03-27FDA Approved: ALLERGY CONGESTION RELIEF — Supplemental Application (Kroger Company)
FDA approved Kroger's supplemental application for Allergy Congestion Relief, a product combining loratadine and pseudoephedrine sulfate. It…
-
FDA approval · 2009-03-24FDA Approved: LORATADINE ALLERGY RELIEF — Supplemental Application (DISCOUNT DRUG MART)
FDA approved a supplemental application for Loratadine Allergy Relief from Discount Drug Mart.
-
FDA approval · 2009-03-20FDA Approved: COUNTERACT ALLERGY — Supplemental Application (Melaleuca, Inc.)
FDA approved a supplemental application for COUNTERACT ALLERGY (loratadine) from Melaleuca, Inc. This approval confirms the product as an ap…
-
FDA label_change · 2009-03-20FDA Approved: LORATADINE ANTIHISTAMINE — Supplemental Application (Padagis Israel Pharmaceuticals Ltd)
FDA approves a supplemental labeling application for loratadine antihistamine from Padagis Israel Pharmaceuticals Ltd, resulting in updated …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2009-03-19FDA Approved: CAREONE ALLERGY RELIEF — Supplemental Application (American Sales Company)
FDA's entry documents a supplemental application for CAREONE ALLERGY RELIEF (fexofenadine HCl) submitted by American Sales Company.
-
FDA approval · 2009-03-13FDA Approved: CHILDRENS ZYRTEC — Supplemental Application (Kenvue Brands LLC)
The FDA approved a supplemental application for Children's Zyrtec (cetirizine hydrochloride) filed by Kenvue Brands LLC.
-
CLINICAL_TRIALS trial_result · 2009-03-09Clinical Trial Update: Efficacy and Safety of Grazax in Children [Phase 3]
Phase 3 trial evaluating the efficacy and safety of Grazax for allergic rhinitis in children has completed.
-
CLINICAL_TRIALS trial_result · 2009-03-06Clinical Trial Update: Study for the Treatment of Intermittent Allergic Rhinitis With Desloratadine (Study P04683) [Phase 3]
Phase 3 trial evaluating desloratadine for intermittent allergic rhinitis completed with results posted in 2009.
-
CLINICAL_TRIALS trial_result · 2009-02-24Clinical Trial Update: OC000459 Dose Finding Study in Hay Fever Sufferers. [Phase 2]
A completed Phase 2 dose-finding study of OC000459 for allergic rhinitis (hay fever) conducted by Oxagen Ltd. The study status is COMPLETED.
-
FDA approval · 2009-02-19FDA Approved: HIVES RELIEF — Original Application (WALGREEN COMPANY)
FDA approved Walgreen's HIVES RELIEF as an original ANDA for cetirizine tablets (cetirizine hydrochloride). This provides a generic option f…
-
FDA approval · 2009-01-29FDA Approved: CLARITIN REDITABS — Supplemental Application (Bayer Healthcare LLC.)
FDA approved a supplemental application for Claritin RediTabs (loratadine) from Bayer Healthcare LLC.
-
CLINICAL_TRIALS research · 2009-01-23Clinical Trial Update: Comparative Study of Sinol and Sinol-M in Patients With Congestion Due to Allergic Rhinitis [Phase 4]
Phase 4 clinical trial update comparing Sinol and Sinol-M for congestion associated with allergic rhinitis.
-
CLINICAL_TRIALS trial_result · 2009-01-22Clinical Trial Update: Influence of Probiotics on Prevention of Atopy, Atopic Disease and Immunological Responses [Phase 2]
Phase 2 clinical trial investigating whether probiotics can prevent atopy and related atopic diseases, including eczema (atopic dermatitis),…
-
CLINICAL_TRIALS trial_result · 2008-11-18Clinical Trial Update: Montelukast in Mild Asthmatic Children With Allergic Rhinitis (0476-367) [Phase 4]
Phase 4 trial update of montelukast in mild asthmatic children with allergic rhinitis. The study has completed and results were posted.
-
CLINICAL_TRIALS research · 2008-11-07Clinical Trial Update: Analysis of Immunological Reactions to Foods in Birch Pollen-Allergic Patients
This clinical trial update analyzes immunological reactions to foods in birch pollen-allergic patients, focusing on implications for allergi…
-
FDA approval · 2008-10-21FDA Approved: CLARITIN REDITABS — Supplemental Application (Bayer HealthCare LLC)
FDA approved a supplemental application for Claritin RediTabs (loratadine) from Bayer HealthCare LLC. This action approves the loratadine Re…
-
FDA approval · 2008-10-21FDA Approved: CLARITIN REDITABS — Supplemental Application (Bayer Healthcare LLC.)
FDA approves a supplemental application for Claritin RediTabs (loratadine) from Bayer Healthcare LLC.
-
FDA label_change · 2008-10-21FDA Approved: CLARITIN CHEWABLE GRAPE AND BUBBLEGUM — Supplemental Application (Bayer HealthCare LLC.)
FDA approved a labeling supplement for Claritin Chewable Grape and Bubblegum (loratadine) by Bayer HealthCare LLC.
-
CLINICAL_TRIALS research · 2008-10-13Clinical Trial Update: Exploration Of Key Targets And Biomarkers Involved In An Allergic Response In Subjects With Allergic Rhinitis (Hay Fever) [Phase 1]
Phase 1 clinical trial exploring targets and biomarkers involved in allergic responses in subjects with allergic rhinitis; the study is comp…
-
FDA label_change · 2008-10-08FDA Approved: CLARITIN CHEWABLE GRAPE AND BUBBLEGUM — Supplemental Application (Bayer HealthCare LLC.)
FDA supplemental application approval for Claritin Chewable Grape and Bubblegum (loratadine) to add a new chewable flavor formulation, updat…
-
FDA approval · 2008-10-06FDA Approved: CETIRIZINE HYDROCHLORIDE — Original Application (Bionpharma Inc.)
FDA approved Bionpharma Inc.'s original application for cetirizine hydrochloride, a generic antihistamine for allergic rhinitis and chronic …
-
CLINICAL_TRIALS trial_result · 2008-09-30Clinical Trial Update: Assessment of Grazax® Treatment Compliance [Phase 3]
Phase 3 trial assessing Grazax treatment compliance in allergic rhinitis has completed.
-
FDA label_change · 2008-09-19FDA Approved: NASACORT ALLERGY 24HR — Supplemental Application (Chattem, Inc.)
The FDA approved a supplemental application for NASACORT ALLERGY 24HR (triamcinolone acetonide) filed by Chattem, Inc.
-
CLINICAL_TRIALS trial_result · 2008-08-18Clinical Trial Update: Primary Prevention of Atopic Disease by Perinatal Administration of Probiotics [NA]
A completed clinical trial evaluated whether perinatal administration of probiotics can prevent atopic diseases in children.